Published in Am J Physiol on February 01, 1996
PTG gene deletion causes impaired glycogen synthesis and developmental insulin resistance. J Clin Invest (2003) 1.27
Progesterone increases skeletal muscle mitochondrial H2O2 emission in nonmenopausal women. Am J Physiol Endocrinol Metab (2010) 0.97
Ultraendurance exercise increases the production of reactive oxygen species in isolated mitochondria from human skeletal muscle. J Appl Physiol (1985) (2010) 0.93
Skeletal muscle fat and carbohydrate metabolism during recovery from glycogen-depleting exercise in humans. J Physiol (2003) 0.93
Granulocyte colony-stimulating factor (G-CSF): A saturated fatty acid-induced myokine with insulin-desensitizing properties in humans. Mol Metab (2016) 0.89
Leptin, catecholamines and free fatty acids related to reduced recovery delays after training. Eur J Appl Physiol (2004) 0.77
Null effect of ginsenoside Rb1 on improving glycemic status in men during a resistance training recovery. J Int Soc Sports Nutr (2015) 0.75
The Accumulative Effect of Concentric-Biased and Eccentric-Biased Exercise on Cardiorespiratory and Metabolic Responses to Subsequent Low-Intensity Exercise: A Preliminary Study. J Hum Kinet (2015) 0.75
Implications of Impaired Endurance Peffects of endurance training orformance following Single Bouts of Resistance Training: An Alternate Concurrent Training Perspective. Sports Med (2017) 0.75
Low back pain in relation to lumbar disc degeneration. Spine (Phila Pa 1976) (2000) 4.39
Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature (1995) 3.78
Is skin preparation necessary before insulin injection? Lancet (1978) 2.15
Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group. Diabetes Care (1996) 2.11
Muscle-eye-brain disease (MEB) Brain Dev (1989) 2.00
Response of the jejunal mucosa to cow's milk in the malabsorption syndrome with cow's milk intolerance. A light- and electron-microscopic study. Acta Paediatr Scand (1973) 1.98
Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients. Ann Intern Med (1980) 1.96
Glucose transporter protein content and glucose transport capacity in rat skeletal muscles. Am J Physiol (1990) 1.91
Disc degeneration of the lumbar spine in relation to overweight. Int J Obes (Lond) (2005) 1.90
Myopathy and malignant hyperpyrexia. Lancet (1970) 1.87
Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): molecular genetics, clinical experience, and fetal morphology. Am J Med Genet (1998) 1.85
Natural course of insulin resistance in type I diabetes. N Engl J Med (1986) 1.82
Hyperuricemia and insulin resistance. J Clin Endocrinol Metab (1994) 1.82
Congenital nephrotic syndrome: prenatal diagnosis and genetic counselling by estimation of aminotic-fluid and maternal serum alpha-fetoprotein. Lancet (1976) 1.82
Estimation of weights and tensions and apparent involvement of a "sense of effort". Exp Neurol (1974) 1.67
Congenital nephrotic syndrome (NPHS1): features resulting from different mutations in Finnish patients. Kidney Int (2000) 1.65
Iron-overload disease in infants involving fetal growth retardation, lactic acidosis, liver haemosiderosis, and aminoaciduria. Lancet (1998) 1.63
Familial congenital diaphragmatic defects: aspects of etiology, prenatal diagnosis, and treatment. Am J Med Genet (1984) 1.61
Osteitis caused by bacille Calmette-Guérin vaccination: a retrospective analysis of 222 cases. J Infect Dis (1995) 1.61
Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea. Diabetes Obes Metab (2008) 1.58
Hyperglycemia decreases glucose uptake in type I diabetes. Diabetes (1987) 1.58
The glycosaminoglycan content of renal basement membranes in the congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol (1992) 1.55
Physiological importance of dehydroepiandrosterone. Lancet (1994) 1.49
Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. Arterioscler Thromb Vasc Biol (2001) 1.48
Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type I diabetic patients. Diabetes (1990) 1.47
Differentiation of kidney mesenchyme in an experimental model system. Adv Morphog (1968) 1.44
Isolated proteinuria: analysis of a school-age population. J Pediatr (1982) 1.43
Is the treatment of metastatic carcinoid tumor with interferon not as successful as suggested? Cancer (1991) 1.43
"Salla disease": a new lysosomal storage disorder. Arch Neurol (1979) 1.40
Insulin analogues and their potential in the management of diabetes mellitus. Diabetologia (1999) 1.40
Guar gum in insulin-dependent diabetes: effects on glycemic control and serum lipoproteins. Am J Clin Nutr (1992) 1.40
Infantile type of so-called neuronal ceroid-lipofuscinosis. Dev Med Child Neurol (1974) 1.39
Cardiogenic brain embolism: role of anticoagulants. Aust N Z J Med (1989) 1.39
The value of MRI in early Perthes' disease: an MRI study with a 2-year follow-up. Pediatr Radiol (1997) 1.39
Progressive unilateral hypertrophic myopathy: a case study. Muscle Nerve (1993) 1.39
Physical training and insulin sensitivity. Diabetes Metab Rev (1986) 1.37
Increased insulin sensitivity and insulin binding to monocytes after physical training. N Engl J Med (1979) 1.33
Immune brachial plexus neuropathy: suggestive evidence for an inflammatory-immune pathogenesis. Neurology (1996) 1.33
Microscopic hematuria in school children: epidemiology and clinicopathologic evaluation. J Pediatr (1979) 1.31
Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest (1992) 1.30
Association of postmedication hypocortisolism with early first relapse of idiopathic nephrotic syndrome. Lancet (1977) 1.30
Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group. Diabetes (1997) 1.30
Gene deletions in X-linked muscular dystrophy. Am J Hum Genet (1989) 1.29
Infantile type of so-called neuronal ceroid-lipofuscinosis. 2. Morphological and biochemical studies. J Neurol Sci (1973) 1.28
Long-term outcome of primary nephrotic syndrome. Arch Dis Child (1982) 1.28
Infantile type of so-called neuronal ceroid-lipofuscinosis. Histological and electron microscopic studies. Acta Neuropathol (1973) 1.27
Demonstration of laminin, a basement membrane glycoprotein, in routinely processed formalin-fixed human tissues. Histochemistry (1982) 1.27
Cloning and functional expression of a human pancreatic islet glucose-transporter cDNA. Proc Natl Acad Sci U S A (1989) 1.27
Effects of leg exercise on insulin absorption in diabetic patients. N Engl J Med (1978) 1.27
Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia (1998) 1.25
Effect of free fatty acids on glucose uptake and nonoxidative glycolysis across human forearm tissues in the basal state and during insulin stimulation. J Clin Endocrinol Metab (1991) 1.24
Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab (1988) 1.22
Mechanism of enhanced insulin sensitivity in athletes. Increased blood flow, muscle glucose transport protein (GLUT-4) concentration, and glycogen synthase activity. J Clin Invest (1993) 1.22
Infantile type of so-called neuronal ceroid-lipofuscinosis. 1. A clinical study of 15 patients. J Neurol Sci (1973) 1.22
Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status. Leukemia (2006) 1.22
Cellular expression of xanthine oxidoreductase protein in normal human tissues. Lab Invest (1999) 1.20
Congenital nephrotic syndrome. Nephron (1973) 1.19
Health-related quality of life in obese outpatients losing weight with very-low-energy diet and behaviour modification--a 2-y follow-up study. Int J Obes Relat Metab Disord (2003) 1.17
Prenatal diagnosis of Batten's disease. Lancet (1996) 1.17
Gyrate atrophy of the choroid and retina with hyperornithinemia: tubular aggregates and type 2 fiber atrophy in muscle. Neurology (1979) 1.16
Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type I diabetic patients. Diabetes (1992) 1.15
Salla disease: a new lysosomal storage disorder with disturbed sialic acid metabolism. Neurology (1983) 1.13
Prenatal diagnosis of congenital nephrosis in 23 high-risk families. Am J Dis Child (1978) 1.13
Health-related quality of life in WHO class II-III obese men losing weight with very-low-energy diet and behaviour modification: a randomised clinical trial. Int J Obes Relat Metab Disord (2002) 1.12
Lysinuric protein intolerance. Am J Med (1975) 1.11
Exercise and the metabolic syndrome. Diabetologia (1997) 1.11
Lumbar disc degeneration in relation to occupation. Scand J Work Environ Health (1998) 1.11
Cytoplasmic inclusions in the vermiform appendix and skeletal muscle in two types of so-called neuronal ceroid-lipofuscinosis. Brain (1973) 1.11
Effects of altered glucose homeostasis on glucose transporter expression in skeletal muscle of the rat. J Clin Invest (1990) 1.11
Alcohol-induced changes in serum lipoproteins and in their metabolism. Am Heart J (1987) 1.10
Mannosidosis: clinical, fine-structural and biochemical findings in three cases. Acta Paediatr Scand (1973) 1.10
Alpha-actinin in nemaline bodies in congenital nemaline myopathy: immunological confirmation by light and electron microscopy. Neuromuscul Disord (1995) 1.10
Henoch-Schönlein nephritis: long-term prognosis of unselected patients. Arch Dis Child (1981) 1.08
Glycemic control in patients with diabetes in Finland. Diabetes Care (1999) 1.08
Polymorphisms of GLUT2 and GLUT4 genes. Use in evaluation of genetic susceptibility to NIDDM in blacks. Diabetes (1990) 1.07
C-reactive protein compared with white blood cell count and erythrocyte sedimentation rate in the diagnosis of acute appendicitis in children. Acta Chir Scand (1986) 1.06
Changes in lactate dehydrogenase and esterase-specific activities, isozymic patterns, and cellular distribution during the growth cycle of PK cells in vitro. Exp Cell Res (1970) 1.06
Improvement in paraplegia in vertebral Paget's disease treated with calcitonin. Br Med J (1976) 1.06
Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes. J Clin Endocrinol Metab (1984) 1.05
Level of skeletal muscle glucose transporter protein correlates with insulin-stimulated whole body glucose disposal in man. Diabetologia (1991) 1.05
Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy. Diabetologia (2004) 1.05
Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemia clamp. J Clin Endocrinol Metab (1992) 1.05
Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care (1998) 1.04
Correlation between the clinical symptoms and the proportion of mitochondrial DNA carrying the 8993 point mutation in the NARP syndrome. Pediatr Res (1995) 1.04
Insulin-regulated mitochondrial gene expression is associated with glucose flux in human skeletal muscle. Diabetes (1999) 1.04
Structure and costs of health care of diabetic patients in Finland. Diabetes Care (1996) 1.04
Supplementary creatine as a treatment for gyrate atrophy of the choroid and retina. N Engl J Med (1981) 1.03
Glomerular sclerosis in kidneys with congenital nephrotic syndrome (NPHS1). Kidney Int (2006) 1.03
Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy. J Clin Endocrinol Metab (1984) 1.02
Pharmacokinetics and bone effects of budesonide in primary biliary cirrhosis. Aliment Pharmacol Ther (2006) 1.02
Chronic osteomyelitislike disease with negative bacterial cultures. Am J Dis Child (1988) 1.02
A variant of Jansky-Bielschowsky disease. Neuropediatrics (1982) 1.01
Sauna-induced acceleration in insulin absorption from subcutaneous injection site. Br Med J (1980) 1.01
Membranous glomerulonephritis and Landry-Guillain-Barre syndrome. Am J Kidney Dis (1986) 1.01
Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group. Arch Intern Med (1997) 1.01